CDI BIOSCIENCE
CDI Bioscience has developed an innovative technology for increased yield of bioproducts, manufactured in cellular systems. Genetic engineering technology is used to control the metabolism of cells, thus shifting the cell from replicative to production mode (RP Shift®). In particular, this technology has been designed for use in mammalian cells, unlocking their potential to produce proteins, peptides and enzymes. The current design of the technology can be readily translated to bacterial and yeast cellular systems for the production of commercial grade bioproducts.
CDI BIOSCIENCE
Industry:
Biotechnology Genetics
Founded:
2007-03-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.cdibiotech.com
Total Employee:
1+
Status:
Active
Contact:
(608)310-9575
Total Funding:
3 M USD
Founder
Investors List
Battelle Ventures
Battelle Ventures investment in Venture Round - CDI Bioscience
Innovation Valley Partners
Innovation Valley Partners investment in Venture Round - CDI Bioscience
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2001-09-19 | PTC Therapeutics | CDI Bioscience investment in Series D - PTC Therapeutics | 40 M USD |
